scholarly journals Free‐breathing 3D late gadolinium enhancement imaging of the left ventricle using a stack of spirals at 3T

2014 ◽  
Vol 41 (4) ◽  
pp. 1030-1037 ◽  
Author(s):  
Iain T. Pierce ◽  
Jennifer Keegan ◽  
Peter Drivas ◽  
Peter D. Gatehouse ◽  
David N. Firmin
Keyword(s):  
Late Gadolinium Enhancement ◽  
Left Ventricle ◽  
Free Breathing ◽  
Late Gadolinium Enhancement Imaging ◽  
Gadolinium Enhancement

Free-breathing motion-corrected late-gadolinium-enhancement imaging improves image quality in children

2016 ◽  
Vol 46 (7) ◽  
pp. 983-990 ◽  
Author(s):  
Laura Olivieri ◽  
Russell Cross ◽  
Kendall J. O’Brien ◽  
Hui Xue ◽  
Peter Kellman ◽  
...  
Keyword(s):  
Late Gadolinium Enhancement ◽  
Image Quality ◽  
Free Breathing ◽  
Late Gadolinium Enhancement Imaging ◽  
Gadolinium Enhancement ◽  
Breathing Motion

scholarly journals Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes

2020 ◽  
Vol 19 (1) ◽  
Author(s):  
Annemie Stege Bojer ◽  
Martin Heyn Sørensen ◽  
Niels Vejlstrup ◽  
Jens P. Goetze ◽  
Peter Gæde ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Late Gadolinium Enhancement ◽  
Left Ventricle ◽  
Stress Perfusion ◽  
Gadolinium Enhancement ◽  
Unique Identifier ◽  
Maximal Volume ◽  
Ischemic Lesion ◽  
Control Subjects

Abstract Background Cardiovascular magnetic resonance imaging (CMR) have described localised non-ischemic late gadolinium enhancement (LGE) lesions of prognostic importance in various non-ischemic cardiomyopathies. Ischemic LGE lesions are prevalent in diabetes (DM), but non-ischemic LGE lesions have not previously been described or systematically studied in DM. Methods 296 patients with type 2 DM (T2DM) and 25 sex-matched control subjects underwent echocardiography and CMR including adenosine-stress perfusion, T1-mapping and LGE. Results 264 patients and all control subjects completed the CMR protocol. 78.4% of patients with T2DM had no LGE lesions; 11.0% had ischemic LGE lesions only; 9.5% had non-ischemic LGE lesions only; and 1.1% had both one ischemic and one non-ischemic lesion. The non-ischemic LGE lesions were situated mid-myocardial in the basal lateral or the basal inferolateral part of the left ventricle and the affected segments showed normal to high wall thickness and normal contraction. Patients with non-ischemic LGE lesions in comparison with patients without LGE lesions had increased myocardial mass (150 ± 34 vs. 133 ± 33 g, P = 0.02), average E/e’(9.9 IQR8.7–12.6 vs. 8.8 IQR7.4–10.7, P = 0.04), left atrial maximal volume (102 IQR84.6–115.2 vs. 91 IQR75.2–100.0 mL, P = 0.049), NT-proBNP (8.9 IQR5.9–19.7 vs. 5.9 IQR5.9–10.1 µmol/L, P = 0.02) and high-sensitive troponin (15.6 IQR13.0–26.1 vs. 13.0 IQR13.0–14.6 ng/L, P = 0.007) and a higher prevalence of retinopathy (48 vs. 25%, P = 0.009) and autonomic neuropathy (52 vs. 30.5%, P = 0.005). Conclusion A specific LGE pattern with lesions in the basal lateral or the basal inferolateral part of the left ventricle was found in patients with type 2 diabetes. Trial registrationhttps://www.clinicaltrials.gov. Unique identifier: NCT02684331.

scholarly journals Dynamic TI for late gadolinium enhancement imaging in atrial fibrillation

2012 ◽  
Vol 14 (S1) ◽  
Author(s):  
Jennifer Keegan ◽  
Peter D Gatehouse ◽  
Sonya V Babu-Naryanan ◽  
Rick Wage ◽  
David N Firmin
Keyword(s):  
Atrial Fibrillation ◽  
Late Gadolinium Enhancement ◽  
Late Gadolinium Enhancement Imaging ◽  
Gadolinium Enhancement
Sign in / Sign up

Export Citation Format

Share Document